LOS ANGELES--(BUSINESS WIRE)--Goldberg Law PC (www.Goldberglawpc.com) announces that a class action lawsuit has been filed in the United States District Court for the District of New Jersey against Valeant Pharmaceuticals International, Inc. (“Valeant” or the “Company”) (NYSE: VRX), for alleged violations of the federal securities laws. Investors who purchased or otherwise acquired shares between February 23, 2015 and October 20, 2015, are advised to contact the firm in advance of the lead plaintiff motion deadline.
If you are a shareholder who suffered a loss during the Class Period, we advise you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 13650 Marina Pointe Dr. Suite 1404, Marina Del Rey, CA 90292, at 800-977-7401, to discuss your rights without cost to you. You can also reach us through the firm’s website at http://www.Goldberglawpc.com, or by email at email@example.com.
The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
According to the complaint, on October 14, 2015, the Company announced that it had been subpoenaed by U.S. prosecutors seeking information on its pricing decisions, drug distribution and patient assistance programs. When the truth was revealed, shares dropped causing investors harm.
If you have any questions concerning your legal rights in this case, please immediately contact Goldberg Law PC at 800-977-7401, or visit our website at http://www.Goldberglawpc.com, or email us at firstname.lastname@example.org.
Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.